Authors: GUPTA E MICK R RAMIREZ J WANG XL LESTINGI TM VOKES EE RATAIN MJ

Citation: E. Gupta et al., PHARMACOKINETIC AND PHARMACODYNAMIC EVALUATION OF THE TOPOISOMERASE INHIBITOR IRINOTECAN IN CANCER-PATIENTS, Journal of clinical oncology, 15(4), 1997, pp. 1502-1510

Authors: MICK R VOKES EE LESTINGI TM GRAYSTERN W FLEMING GF SCHILSKY RL RATAIN MJ

Citation: R. Mick et al., ETOPOSIDE COMBINED WITH INTERFERON ALFA-2B - NOVEL EXPLOITATION OF ESTABLISHED ETOPOSIDE PHARMACOKINETICS AND PHARMACODYNAMICS, Clinical pharmacology and therapeutics, 59(3), 1996, pp. 349-359

Authors: VOGELZANG NJ LESTINGI TM SUDAKOFF G

Citation: Nj. Vogelzang et al., PHASE-I STUDY OF IMMUNOTHERAPY OF METASTATIC RENAL-CELL CARCINOMA BY DIRECT GENE-TRANSFER INTO METASTATIC LESIONS, Human gene therapy, 5(11), 1994, pp. 1357-1370

Authors: GUPTA E LESTINGI TM MICK R RAMIREZ J VOKES EE RATAIN MJ

Citation: E. Gupta et al., RELATIONSHIP OF CPT-11 INDUCED DIARRHEA TO GLUCURONIDATION OF ITS METABOLITE SN-38, Clinical research, 42(3), 1994, pp. 10000394-10000394

Authors: GUPTA F LESTINGI TM MICK R RAMIREZ J VOKES EE RATAIN MJ

Citation: F. Gupta et al., METABOLIC-FATE OF IRINOTECAN IN HUMANS - CORRELATION OF GLUCURONIDATION WITH DIARRHEA, Cancer research, 54(14), 1994, pp. 3723-3725